Valeo Financial Advisors, LLC Sorrento Therapeutics, Inc. Transaction History

Valeo Financial Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$0.74 - $1.83 $740 - $1,830	1,000 Added 3.78%	27,473 $24,000
Q3 2022 Oct 31, 2022	BUY	$1.51 - $2.88 $10,570 - $20,160	7,000 Added 35.95%	26,473 $42,000
Q1 2022 Apr 28, 2022	BUY	$2.0 - $4.9 $10,000 - $24,500	5,000 Added 34.55%	19,473 $45,000
Q4 2021 Jan 07, 2022	BUY	$4.65 - $7.23 $465 - $723	100 Added 0.7%	14,473 $67,000
Q3 2021 Nov 02, 2021	BUY	$7.41 - $10.99 $10,173 - $15,089	1,373 Added 10.56%	14,373 $110,000
Q1 2021 Apr 12, 2021	BUY	$7.03 - $16.51 $21,090 - $49,530	3,000 Added 30.0%	13,000 $108,000
Q3 2020 Oct 28, 2020	BUY	$6.17 - $18.82 $37,020 - $112,920	6,000 Added 150.0%	10,000 $112,000
Q2 2020 Jul 20, 2020	BUY	$1.73 - $6.76 $6,920 - $27,040	4,000 New	4,000 $25,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.